Steve Schonfeld’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Buy
+26,154
New +$285K ﹤0.01% 2329
2026
Q1
– Sell
-113,978
Closed -$2.85M – 2537
2025
Q4
$2.85M Buy
+113,978
New +$2.03M 0.01% 753
2025
Q2
– Sell
-20,020
Closed -$75.3K – 2395
2025
Q1
$75.3K Sell
20,020
-485,380
-96% -$2.44M ﹤0.01% 2047
2024
Q4
$2.95M Buy
505,400
+43,474
+9% +$434K 0.02% 683
2024
Q3
$5.52M Buy
461,926
+345,000
+295% +$4.41M 0.04% 510
2024
Q2
$1.27M Sell
116,926
-86,899
-43% -$942K 0.01% 1103
2024
Q1
$2.31M Buy
+203,825
New +$2.63M 0.02% 942
2023
Q4
– Sell
-72,369
Closed -$894K – 2122
2023
Q3
$894K Sell
72,369
-53,243
-42% -$543K 0.01% 1052
2023
Q2
$1.13M Buy
+125,612
New +$758K 0.01% 931
2022
Q4
– Sell
-14,700
Closed -$40K – 2888
2022
Q3
$40K Sell
14,700
-17,200
-54% -$72.9K ﹤0.01% 2661
2022
Q2
$130K Sell
31,900
-14,300
-31% -$45.4K ﹤0.01% 2068
2022
Q1
$197K Buy
+46,200
New +$255K ﹤0.01% 1980

Other funds holding OLMA

Steve Schonfeld's OLMA Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Olema Oncology (OLMA) in Q3 2026: 26,154 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #2329 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in OLMA as recently as Q4 2025.

Steve Schonfeld first reported a position in OLMA in Q1 2022 and has held it in 12 quarters since. The position peaked at $5.52M in Q3 2024. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Steve Schonfeld held 26,154 shares of Olema Oncology worth $226K as of Q3 2026.
  • Olema Oncology was a new Steve Schonfeld position in Q3 2026.
  • Olema Oncology made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2329 holding.
  • Steve Schonfeld first reported a position in Olema Oncology in Q1 2022 and has held it in 12 quarters since.
  • Steve Schonfeld's Olema Oncology position peaked at $5.52M in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.